Accès gratuit
Volume 25, Numéro 3, Mai 2016
Page(s) 274 - 286
Section Mise Au Point / Update
Publié en ligne 11 mars 2016
  • Laterre PF, Colardyn F, Delmee M, et al (2006) Antimicrobial therapy for intra-abdominal infections: guidelines from the Infectious Disease Advisory Board (IDAB). Acta Chir Belg 106:2–21 [CrossRef] [PubMed] [Google Scholar]
  • Guirao X, Arias J, Badia JM, et al (2009) Recommendations in the empiric anti-infective agents of intra-abdominal infection. Rev Esp Quimioter 22:151–72 [PubMed] [Google Scholar]
  • Solomkin JS, Mazuski JE, Bradley JS, et al (2010) Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 50:133–64 [CrossRef] [PubMed] [Google Scholar]
  • Chow AW, Evans GA, Nathens AB, et al (2010) Canadian practice guidelines for surgical intra-abdominal infections. Can J Infect Dis Med Microbiol 21:11–37 [PubMed] [Google Scholar]
  • Bodmann KF (2010) Complicated intra-abdominal infections: pathogens, resistance. Recommendations of the Infectliga on antbiotic therapy. Chirurg 81:38–49 [CrossRef] [PubMed] [Google Scholar]
  • Sartelli M, Viale P, Catena F, et al (2013) 2013 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg 8:3 [CrossRef] [Google Scholar]
  • Montravers P, Dupont H, Leone M, et al (2015) Guidelines for management of intra-abdominal infections. Anaesth Crit Care Pain Med 34:117–30 [CrossRef] [PubMed] [Google Scholar]
  • Panhofer P, Izay B, Riedl M, et al (2009) Age, microbiology and prognostic scores help to differentiate between secondary and tertiary peritonitis. Langenbecks Arch Surg 394:265–71 [CrossRef] [PubMed] [Google Scholar]
  • Weiss G, Meyer F, Lippert H (2006) Infectiological diagnostic problems in tertiary peritonitis. Langenbecks Arch Surg 391:473–82 [CrossRef] [PubMed] [Google Scholar]
  • Chromik AM, Meiser A, Holling J, et al (2009) Identification of patients at risk for development of tertiary peritonitis on a surgical intensive care unit. J Gastrointest Surg 13:1358–67 [CrossRef] [PubMed] [Google Scholar]
  • Montravers P, Dufour G, Guglielminotti J, et al (2015) Dynamic changes of microbial flora and therapeutic consequences in persistent peritonitis. Crit Care 19:70 [CrossRef] [PubMed] [Google Scholar]
  • Montravers P, Augustin P, Zappella N, et al (2015) Diagnosis and management of the postoperative surgical and medical complications of bariatric surgery. Anaesth Crit Care Pain Med 34:45–52 [CrossRef] [PubMed] [Google Scholar]
  • Holzheimer RG, Gathof B (2003) Re-operation for complicated secondary peritonitis - how to identify patients at risk for persistent sepsis. Eur J Med Res 8:125–34 [PubMed] [Google Scholar]
  • Kermarrec N, Marmuse JP, Faivre J, et al (2008) High mortality rate for patients requiring intensive care after surgical revision following bariatric surgery. Obes Surg 18:171–8 [CrossRef] [PubMed] [Google Scholar]
  • Montravers P, Guglielminotti J, Zappella N, et al (2013) Clinical features and outcome of postoperative peritonitis following bariatric surgery. Obes Surg 23:1536–44 [CrossRef] [PubMed] [Google Scholar]
  • van Ruler O, Lamme B, Gouma DJ, et al (2007) Variables associated with positive findings at relaparotomy in patients with secondary peritonitis. Crit Care Med 35:468–76 [CrossRef] [PubMed] [Google Scholar]
  • van Ruler O, Kiewiet JJ, Boer KR, et al (2011) Failure of available scoring systems to predict ongoing infection in patients with abdominal sepsis after their initial emergency laparotomy. BMC Surg 11:38 [CrossRef] [PubMed] [Google Scholar]
  • Paugam-Burtz C, Dupont H, Marmuse JP, et al (2002) Daily organ-system failure for diagnosis of persistent intra-abdominal sepsis after postoperative peritonitis. Intensive Care Med 28:594–8 [CrossRef] [PubMed] [Google Scholar]
  • Paugam-Burtz C, Mantz J, Dupont H, et al (2007) Procalcitonin levels and sequential organ failure assessment scores in secondary peritonitis. Arch Surg 142:803; author reply 03–4 [CrossRef] [Google Scholar]
  • Jung B, Molinari N, Nasri M, et al (2013) Procalcitonin biomarker kinetics fails to predict treatment response in perioperative abdominal infection with septic shock. Crit Care 17:R255 [CrossRef] [PubMed] [Google Scholar]
  • Rau BM, Frigerio I, Buchler MW, et al (2007) Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study. Arch Surg 142:134–42 [CrossRef] [PubMed] [Google Scholar]
  • Dupont H, Carbon C, Carlet J (2000) Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group. Antimicrob Agents Chemother 44:2028–33 [CrossRef] [PubMed] [Google Scholar]
  • Montravers P, Lepape A, Dubreuil L, et al (2009) Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study. J Antimicrob Chemother 63:785–94 [CrossRef] [PubMed] [Google Scholar]
  • Riche FC, Dray X, Laisne MJ, et al (2009) Factors associated with septic shock and mortality in generalized peritonitis: comparison between community-acquired and postoperative peritonitis. Crit Care 13:R99 [CrossRef] [PubMed] [Google Scholar]
  • Augustin P, Kermarrec N, Muller-Serieys C, et al (2010) Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis. Crit Care 14:R20 [CrossRef] [PubMed] [Google Scholar]
  • Seguin P, Fedun Y, Laviolle B, et al (2010) Risk factors for multidrug-resistant bacteria in patients with post-operative peritonitis requiring intensive care. J Antimicrob Chemother 65:342–6 [CrossRef] [PubMed] [Google Scholar]
  • Seguin P, Laviolle B, Chanavaz C, et al (2006) Factors associated with multidrug-resistant bacteria in secondary peritonitis: impact on antibiotic therapy. Clin Microbiol Infect 12:980–5 [CrossRef] [PubMed] [Google Scholar]
  • Swenson BR, Metzger R, Hedrick TL, et al (2009) Choosing antibiotics for intra-abdominal infections: what do we mean by “high risk”? Surg Infect (Larchmt) 10:29–39 [CrossRef] [PubMed] [Google Scholar]
  • De Ruiter J, Weel J, Manusama E, et al (2009) The epidemiology of intra-abdominal flora in critically ill patients with secondary and tertiary abdominal sepsis. Infection 37:522–7 [CrossRef] [PubMed] [Google Scholar]
  • Dupont H, Vael C, Muller-Serieys C, et al (2008) Prospective evaluation of virulence factors of enterococci isolated from patients with peritonitis: impact on outcome. Diagn Microbiol Infect Dis 60:247–53 [CrossRef] [Google Scholar]
  • Seguin P, Brianchon C, Launey Y, et al (2012) Are enterococci playing a role in postoperative peritonitis in critically ill patients? Eur J Clin Microbiol Infect Dis 31:1479–85 [CrossRef] [PubMed] [Google Scholar]
  • Dupont H, Paugam-Burtz C, Muller-Serieys C, et al (2002) Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients. Arch Surg 137:1341–6; (discussion 47) [CrossRef] [PubMed] [Google Scholar]
  • Montravers P, Mira JP, Gangneux JP, et al (2011) A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units. Clin Microbiol Infect 17:1061–7 [CrossRef] [PubMed] [Google Scholar]
  • Zappella N, Desmard M, Chochillon C, et al (2015) Positive peritoneal fluid fungal cultures in postoperative peritonitis after bariatric surgery. Clin Microbiol Infect 21:853.e1–e3 [CrossRef] [Google Scholar]
  • Leon C, Ruiz-Santana S, Saavedra P, et al (2006) A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 34:730–7 [CrossRef] [PubMed] [Google Scholar]
  • Dupont H, Bourichon A, Paugam-Burtz C, et al (2003) Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis? Crit Care Med 31:752–7 [CrossRef] [PubMed] [Google Scholar]
  • Bedikian A, Okamoto MP, Nakahiro RK, et al (1994) Pharmacokinetics of meropenem in patients with intra-abdominal infections. Antimicrob Agents Chemother 38:151–4 [CrossRef] [PubMed] [Google Scholar]
  • Karjagin J, Lefeuvre S, Oselin K, et al (2008) Pharmacokinetics of meropenem determined by microdialysis in the peritoneal fluid of patients with severe peritonitis associated with septic shock. Clin Pharmacol Ther 83:452–9 [CrossRef] [PubMed] [Google Scholar]
  • Seguin P, Verdier MC, Chanavaz C, et al (2009) Plasma and peritoneal concentration following continuous infusion of cefotaxime in patients with secondary peritonitis. J Antimicrob Chemother 63:564–7 [CrossRef] [PubMed] [Google Scholar]
  • Buijk SL, Gyssens IC, Mouton JW, et al (2002) Pharmacokinetics of ceftazidime in serum and peritoneal exudate during continuous versus intermittent administration to patients with severe intra-abdominal infections. J Antimicrob Chemother 49:121–8 [CrossRef] [PubMed] [Google Scholar]
  • Hites M, Taccone FS, Wolff F, et al (2013) Case-control study of drug monitoring of beta-lactams in obese critically ill patients. Antimicrob Agents Chemother 57:708–15 [CrossRef] [PubMed] [Google Scholar]
  • Grau S, Luque S, Campillo N, et al (2015) Plasma and peritoneal fluid population pharmacokinetics of micafungin in post-surgical patients with severe peritonitis. J Antimicrob Chemother 70:2854–61 [CrossRef] [PubMed] [Google Scholar]
  • Sartelli M, Abu-Zidan FM, Ansaloni L, et al (2015) The role of the open abdomen procedure in managing severe abdominal sepsis: WSES position paper. World J Emerg Surg 10:35 [CrossRef] [Google Scholar]
  • van Ruler O, Mahler CW, Boer KR, et al (2007) Comparison of on-demand vs planned relaparotomy strategy in patients with severe peritonitis: a randomized trial. JAMA 298:865–72 [CrossRef] [PubMed] [Google Scholar]
  • Kirkpatrick AW, Roberts DJ, De Waele J, et al (2013) Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med 39:1190–206 [CrossRef] [PubMed] [Google Scholar]
  • Dupont H, Friggeri A, Touzeau J, et al (2011) Enterococci increase the morbidity and mortality associated with severe intra-abdominal infections in elderly patients hospitalized in the intensive care unit. J Antimicrob Chemother 66:2379–85 [CrossRef] [PubMed] [Google Scholar]
  • Gauzit R, Pean Y, Barth X, et al (2009) Epidemiology, management, and prognosis of secondary non-postoperative peritonitis: a French prospective observational multicenter study. Surg Infect (Larchmt) 10:119–27 [CrossRef] [PubMed] [Google Scholar]
  • Babinchak T, Ellis-Grosse E, Dartois N, et al (2005) The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. Clin Infect Dis 41:S354–S67 [CrossRef] [PubMed] [Google Scholar]
  • Chen Z, Wu J, Zhang Y, et al (2010) Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial. BMC Infect Dis 10:217 [CrossRef] [PubMed] [Google Scholar]
  • Eckmann C, Montravers P, Bassetti M, et al (2013) Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studies. J Antimicrob Chemother 68:ii25–ii35 [CrossRef] [PubMed] [Google Scholar]
  • Montravers P, Dupont H, Gauzit R, et al (2006) Candida as a risk factor for mortality in peritonitis. Crit Care Med 34:646–52 [CrossRef] [PubMed] [Google Scholar]
  • Bassetti M, Righi E, Ansaldi F, et al (2015) A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med 41:1601–10 [CrossRef] [PubMed] [Google Scholar]
  • Leon C, Ruiz-Santana S, Saavedra P, et al (2012) Value of beta-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions. Intensive Care Med 38:1315–25 [CrossRef] [PubMed] [Google Scholar]
  • Tissot F, Lamoth F, Hauser PM, et al (2013) Beta-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis. Am J Respir Crit Care Med 188:1100–9 [CrossRef] [PubMed] [Google Scholar]
  • Martin-Mazuelos E, Loza A, Castro C, et al (2015) Beta-D-glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis. Intensive Care Med 41:1424–32 [CrossRef] [PubMed] [Google Scholar]
  • Bassetti M, Marchetti M, Chakrabarti A, et al (2013) A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med 39:2092–106 [CrossRef] [PubMed] [Google Scholar]
  • Pappas PG, Kauffman CA, Andes DR, et al (2015) Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis (en cours de publication) [Google Scholar]
  • Senn L, Eggimann P, Ksontini R, et al (2009) Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients. Intensive Care Med 35:903–8 [CrossRef] [PubMed] [Google Scholar]
  • Knitsch W, Vincent JL, Utzolino S, et al (2015) A randomized, placebo-controlled trial of preemptive antifungal therapy for the prevention of invasive candidiasis following gastrointestinal surgery for intra-abdominal infections. Clin Infect Dis 61:1671–8 [PubMed] [Google Scholar]
  • Sawyer RG, Claridge JA, Nathens AB, et al (2015) Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med 372:1996–2005 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.